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INTRODUCTION
Giant cell tumor of bone (GCTB) is a primary 
intramedullary bone tumor that is histologically 
benign but clinically shows local aggression with 
significant osteolysis (3,5,13,14). The tumor is 
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named for its numerous multinucleated giant 
cells of monocytic-macrophageal origin which 
are principally responsible for the extensive bone 
resorption that is characteristic of GCTB (2,8). 
However, the neoplastic components of GCTB are the 
spindle-like stromal cells, which promote giant cell 
formation and largely direct the pathogenesis of the 
tumor (2,8). It accounts for about 5% of primary bone 
tumors and predominantly affected the epiphyses of 
long bones (3,13,14). This tumor appears most often 
in the third and fourth decade of life with a slight 
predilection for females (3,13,14). Surgical treatment 
options include intralesional excision or segmental 
resection (3,6,9,13,14). 
In order to further clarify the GCTB, we examined 
this lesion in ten patients operated on in our hospital 
ABSTRACT
Giant cell tumor of bone is an osseous neoplasm that is histologically benign but clinically shows local ag-
gression and high rate of recurrence. The histogenesis of this lesion remains unclear. The histological ap-
pearance does not predict the clinical outcome and there are still many unanswered questions with regard 
to both its treatment and prognosis. In order to further clarify this lesion, we examined ultrastructural-
ly and immunohistochemically the tumor mononuclear cells in ten patients operated on in our hospital for 
matrix metalloproteinase-9. Positive reaction was detected in the spindle-like stromal cells of giant cell tu-
mor of bone and these cells had the ultrastructural characteristics of fibroblastic cells. The other mononu-
clear cells did not express matrix metalloproteinase-9 and showed ultrastuctural characteristics of macro-
phage-like cells. The positive reaction for matrix metalloproteinase-9 in all patients clearly shows that this 
protease may play a key role in the pathophysiology of giant cell tumor of bone.
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ultrastructurally and immunohistochemically for 
matrix metalloproteinase-9 (MMP-9).
MATERIALS AND METHODS
We examined material from ten patients with 
GCTB that were operated on in our hospital (6 female 
and 4 male). The medico-legal office and local Ethic 
Committee approved this study.
Immunohistochemistry preparation protocol 
for MMP-9: Tissue samples were fixed in 10% 
buffered formalin for 24 h, then dehydrated in 
increasing concentrations of ethanol. Alcohol was 
removed using cedar oil until samples became 
translucent. Samples were rinsed in xylene and 
embedded in paraffin. Two to three serial paraffin 
sections, 7 µm in thickness, were mounted on slides 
previously coated with chrome-gelatine. Sections 
were deparaffinized, dehydrated, and washed in 
phosphate buffered saline (PBS, pH 7.4). Endogenous 
peroxidase activity was blocked with 3% H2o2 for 
15 min at room temperature. The sections were 
rinsed in PBS and nonspecific binding sites were 
blocked with 2.5% horse serum in PBS (Vector 
Laboratories Inc., Burlingame, CA) for 20 min. 
Primary polyclonal antibody for MMP-9 (Sigma 
Co., St. Louis, Mo) at a dilution 1:500 was added 
and sections were incubated overnight at 4ºC, rinsed 
in PBS and incubated with biotinylated horse anti-
rabbit IgG (Vector Laboratories Inc., Burlingame, 
CA), diluted 1:400 in 1.5% horse serum for 60 min 
at room temperature. Sections were rinsed as before 
and incubated with streptavidin-HRP (Vector 
Laboratories Inc., Burlingame, CA) for 45 min at 
room temperature. Antibody binding was visualized 
using 3,3́ -diaminobenzidine tetrahydrochloride 
(DAB; Sigma Co., St. Louis, Mo) as chromogen for 
10 min. Sections were counterstained with Mayer‘s 
haematoxylin, dehydrated in graded series of ethanol, 
cleared in xylene, and cover-slipped with Canada 
balsam. For controls, the primary antibody was 
replaced with isotype-matched anti-rabbit IgG. For 
representation of classical pathological diagnosis we 
used routine staining method haematoxylin-eosin.
Electron microscopy preparation protocol: 
Tumor tissues were fixed in 3% glutaraldehyde for 
2 h. After that the tissue samples were postfixed 
in 1% oso4 in PBS for 2 h. Then the slices were 
dehydrated and embedded in Durkupan (Fluka, 
Buchs, Switzerland). All slices were processed with 
disectional microscope and cut with ultramicrotome 
(LKB, Stockholm-Bromma, Sweden). Finally, they 
were mounted, covered, contrasted, and examined 
with an electron microscope Hitachi 500.
RESULTS
Classical histological appearance of 
multinucleated giant cells admixed with mononuclear 
stromal cells was established in all cases.
our results showed positive immunohis-
tochemical reaction for MMP-9 in the spindle-shape 
cells of GCTB (Fig. 1). The polygonal cells were 
negative for MMP-9. 
Ultrastructurally, the spindle-shaped cells 
resembled fibroblastic cells and mitotic activity was 
observed. The formation of deep infoldings of the 
nuclei was observed. Their nuclei also displayed 
delicate chromatin structure with clearly visible 
heterochromatin clumps in the peripheral nuclear 
area. The cytoplasm contained expanded rough 
endoplasmic reticulum, a well-developed Golgi 
apparatus, free ribosomes, polysomes, and irregularly 
shaped mitochondria (Fig. 2). The ultrastructural 
features of the second type of mononuclear cells were 
similar to macrophages (Fig. 3). They had oval nuclei 
with low chromatin density. The cell membrane had 
pseudopodial extensions. The cytoplasm of these cells 
presented relatively abundant rough endoplasmic 
reticulum, well developed Golgi apparatus, variable 
number of mitochondria, lysosomes, and free 
ribosomes.
Fig. 1. Immunohistochemical localization of MMP-9 
(x400)
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DISCUSSION
GCTB is described as a locally invasive tumor 
with a high rate of recurrence and a possibility of 
mainly pulmonary metastases or transformation 
into a malignancy (3,6,9,13,14). In the current 
literature GCTB is described as a predominantly 
osteoclastogenic stromal cell tumor of mesenchymal 
origin (8). It is composed of three cell types – the 
spindle-like stromal cells, mononuclear monocyte 
cells, and multinucleated giant cells (8,16). Тhe 
multinucleated giant cells which mimic osteoclasts 
are principally responsible for the extensive bone 
resorption that is characteristic of GCT (2). However, 
the stromal cells are the main neoplastic component 
of GCTB and have been shown to express and secrete 
a variety of chemotactic factors to enlist pathologic 
components (2,8). Mononuclear monocyte cells 
are considered to be either reactive macrophages 
or osteoclast precursors (2,8). To further examine 
this lesion we studied mononuclear cells in GCTB 
ultrastructurally and immunohistochemically for 
MMP-9. 
Matrix metalloproteinases (MMPs) are 
proteases which play a central role in the catabolism 
of extracellular matrix macromolecules (4,7,10). 
MMPs play an important regulatory role in the 
accelerated breakdown of the extracellular matrix, 
tissue morphogenesis, cell differentiation, tumor 
invasion and metastasis (4,7,10). In this study we 
have shown that the spindle-like stromal cells of 
GCTB express MMP-9 in all studied specimens, 
which clearly shows that this protease has a definite 
role in the pathogenesis of GCTB. Previous studies 
presented that bone matrix destruction via type-I 
collagen degradation (by osteoclasts) leaves behind 
denatured type-I collagen (gelatin), which the 
gelatinases MMP-2 and MMP-9 degrade and cause 
osteolysis (11,15). Ultrastructurally the spindle-
like mononuclear cells resemble fibroblastic cells, 
and some have mitotic activity, which corresponds 
to the other electron microscopic studies of GCTB 
(12,17). These cells also have well-developed rough 
endoplasmic reticulum, which indicates that they 
have a high degree of protein synthesis. The deep 
nuclear infoldings of the nuclei are consistent 
with the view that these cells are truly neoplastic. 
However, similar findings are also observed during 
reparative processes of connective tissues (1). The 
other mononuclear cells do not express MMP-
9 and have the ultrastructural characteristics of 
macrophages, also presented by others (10,12,17). 
There is no convincing ultrastructural evidence to 
suggest that these cells are neoplastic in nature (1).
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